Have a feature idea you'd love to see implemented?
Let us know!
BIO Bio-Rad Laboratories Inc
Price (delayed)
$325.61
Market cap
$9.12B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$27.62
Enterprise value
$10.09B
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley,
Highlights
The EPS has increased by 42% from the previous quarter
The net income rose by 41% QoQ
The equity has contracted by 11% YoY but it has grown by 10% from the previous quarter
The revenue has contracted by 5% YoY
Bio-Rad Laboratories's gross profit has decreased by 3.7% YoY
Key stats
What are the main financial stats of BIO
Market
Valuations
Earnings
Shares outstanding
28M
Market cap
$9.12B
Enterprise value
$10.09B
Price to book (P/B)
1.21
Price to sales (P/S)
3.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.91
Revenue
$2.58B
EBIT
-$956.12M
EBITDA
-$956.12M
Free cash flow
$247.42M
Per share
Balance sheet
Liquidity
EPS
-$27.62
Free cash flow per share
$8.85
Book value per share
$268.66
Revenue per share
$92.32
TBVPS
$353.54
Total assets
$10.6B
Total liabilities
$3.12B
Debt
$1.39B
Equity
$7.49B
Working capital
$2.56B
Debt to equity
0.19
Current ratio
6.14
Quick ratio
4.2
Net debt/EBITDA
-1.02
Margins
Efficiency
Dividend
EBITDA margin
-37.1%
Gross margin
54.4%
Net margin
-30.2%
Operating margin
11.9%
Return on assets
-6.9%
Return on equity
-9.7%
Return on invested capital
-8.6%
Return on capital employed
-9.5%
Return on sales
-37.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BIO stock price
How has the Bio-Rad Laboratories stock price performed over time
Intraday
0.59%
1 week
-7.03%
1 month
-5.1%
1 year
6.35%
YTD
0.84%
QTD
-2.68%
Financial performance
How have Bio-Rad Laboratories's revenue and profit performed over time
Revenue
$2.58B
Gross profit
$1.4B
Operating income
$305.99M
Net income
-$778.69M
Gross margin
54.4%
Net margin
-30.2%
The net margin is up by 42% since the previous quarter
The net income rose by 41% QoQ
BIO's operating income is down by 15% year-on-year and by 8% since the previous quarter
BIO's operating margin is down by 11% year-on-year and by 8% since the previous quarter
Growth
What is Bio-Rad Laboratories's growth rate over time
Valuation
What is Bio-Rad Laboratories stock price valuation
P/E
N/A
P/B
1.21
P/S
3.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.91
The EPS has increased by 42% from the previous quarter
BIO's P/B is 20% below its 5-year quarterly average of 1.5 but 9% above its last 4 quarters average of 1.1
The equity has contracted by 11% YoY but it has grown by 10% from the previous quarter
The stock's price to sales (P/S) is 33% less than its 5-year quarterly average of 5.2
The revenue has contracted by 5% YoY
Efficiency
How efficient is Bio-Rad Laboratories business performance
The ROS has increased by 43% from the previous quarter
The company's return on invested capital rose by 42% QoQ
The ROE is up by 40% since the previous quarter
Bio-Rad Laboratories's ROA has increased by 39% from the previous quarter
Dividends
What is BIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BIO.
Financial health
How did Bio-Rad Laboratories financials performed over time
The total assets has declined by 11% year-on-year but it has increased by 9% since the previous quarter
BIO's total liabilities is down by 10% year-on-year but it is up by 7% since the previous quarter
The debt is 81% smaller than the equity
Bio-Rad Laboratories's debt to equity has increased by 12% YoY but it has decreased by 10% from the previous quarter
The equity has contracted by 11% YoY but it has grown by 10% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.